MEDICAL weight loss
We are all well aware of the obesity epidemic in this country. More than two thirds of Americans are overweight and a third of Americans are obese. Obesity has now surpassed tobacco as the leading cause of preventable deaths. If losing weight was easy, it wouldn't be such a big problem and you probably wouldn't be reading this. But researchers are learning more about the appetite and obesity and some exciting new treatments are emerging.
WEIGHT LOSS MEDICATIONS
Semaglutide 5,000mcg/mL - L-Carnitine 100mg/mL - A once weekly injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity.
TIRZEPATIDE/CYANOCOBALAMIN 10MG/500MCG/ML - A once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. Tirzepatide is a single peptide that triggers the body's receptors for GIP and GLP-1, two natural incretin hormones.
GIP has decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.
-
Substantial A1C reductions
-
Boosted weight loss
-
Improvements in cardiometabolic measures
-
Reduce appetite